Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease.
Kjeldsen SAS, Werge MP, Grandt J, Richter MM, Thing M, Hetland LE, Rashu EB, Jensen AH, Winther-Sørensen M, Kellemann JS, Holst JJ, Junker AE, Serizawa RR, Vyberg M, Gluud LL, Wewer Albrechtsen NJ. Kjeldsen SAS, et al. Among authors: rashu eb. Am J Physiol Gastrointest Liver Physiol. 2024 Oct 1;327(4):G558-G570. doi: 10.1152/ajpgi.00147.2024. Epub 2024 Aug 6. Am J Physiol Gastrointest Liver Physiol. 2024. PMID: 39104323
Glucagon Resistance in Individuals With Obesity and Hepatic Steatosis Can Be Measured Using the GLUSENTIC Test and Index.
Kjeldsen SAS, Richter MM, Jensen NJ, Nilsson MSD, Heinz N, Nybing JD, Linden FH, Høgh-Schmidt E, Boesen MP, Andersen TL, Johannesen HH, Trammell SAJ, Grevengoed TJ, Madsbad S, Vilstrup H, Schiødt FV, Møller A, Rashu EB, Nørgaard K, Schmidt S, Gluud LL, Haugaard SB, Holst JJ, Rungby J, Wewer Albrechtsen NJ. Kjeldsen SAS, et al. Among authors: rashu eb. Diabetes. 2024 Oct 1;73(10):1716-1727. doi: 10.2337/db23-0858. Diabetes. 2024. PMID: 38976454
Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLD.
Verschuren L, Mak AL, van Koppen A, Özsezen S, Difrancesco S, Caspers MPM, Snabel J, van der Meer D, van Dijk AM, Rashu EB, Nabilou P, Werge MP, van Son K, Kleemann R, Kiliaan AJ, Hazebroek EJ, Boonstra A, Brouwer WP, Doukas M, Gupta S, Kluft C, Nieuwdorp M, Verheij J, Gluud LL, Holleboom AG, Tushuizen ME, Hanemaaijer R. Verschuren L, et al. Among authors: rashu eb. Nat Commun. 2024 May 29;15(1):4564. doi: 10.1038/s41467-024-48956-0. Nat Commun. 2024. PMID: 38811591 Free PMC article.
Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease.
Jensen AH, Ytting H, Werge MP, Rashu EB, Hetland LE, Thing M, Nabilou P, Burisch J, Bojsen-Møller KN, Junker AE, Hobolth L, Mortensen C, Tofteng F, Bendtsen F, Møller S, Vyberg M, Serizawa RR, Gluud LL, Wewer Albrechtsen NJ. Jensen AH, et al. Among authors: rashu eb. Am J Physiol Gastrointest Liver Physiol. 2024 Jun 1;326(6):G736-G746. doi: 10.1152/ajpgi.00047.2024. Epub 2024 Apr 16. Am J Physiol Gastrointest Liver Physiol. 2024. PMID: 38625142
Suboptimal diagnostic accuracy of ultrasound and CT for compensated cirrhosis: Evidence from prospective cohort studies.
Hetland LE, Kronborg TM, Thing M, Werge MP, Junker AE, Rashu EB, O'Connell MB, Olsen BH, Jensen AH, Wewer Albrechtsen NJ, Møller S, Hobolth L, Mortensen C, Kimer N, Gluud LL. Hetland LE, et al. Among authors: rashu eb. Hepatol Commun. 2023 Aug 31;7(9):e0231. doi: 10.1097/HC9.0000000000000231. eCollection 2023 Sep 1. Hepatol Commun. 2023. PMID: 37655978 Free PMC article.
Postprandial dysfunction in fatty liver disease.
Grandt J, Jensen AH, Werge MP, Rashu EB, Møller A, Junker AE, Hobolth L, Mortensen C, Johansen CD, Vyberg M, Serizawa RR, Møller S, Gluud LL, Wewer Albrechtsen NJ. Grandt J, et al. Among authors: rashu eb. Physiol Rep. 2023 Apr;11(8):e15653. doi: 10.14814/phy2.15653. Physiol Rep. 2023. PMID: 37078380 Free PMC article. Clinical Trial.
Development of a glucagon sensitivity test in humans: Pilot data and the GLUSENTIC study protocol.
Kjeldsen SAS, Richter MM, Jensen NJ, Nilsson MSD, Heinz N, Nybing JD, Linden FH, Høgh-Schmidt E, Boesen MP, Madsbad S, Vilstrup H, Schiødt FV, Møller A, Nørgaard K, Schmidt S, Rashu EB, Gluud LL, Haugaard SB, Holst JJ, Rungby J, Wewer Albrechtsen NJ. Kjeldsen SAS, et al. Among authors: rashu eb. Peptides. 2023 Mar;161:170938. doi: 10.1016/j.peptides.2022.170938. Epub 2022 Dec 31. Peptides. 2023. PMID: 36596314 Free article.
Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes.
Wewer Albrechtsen NJ, Møller A, Martinussen C, Gluud LL, Rashu EB, Richter MM, Plomgaard P, Goetze JP, Kjeldsen S, Hansen LH, Gustafsson F, Deacon CF, Holst JJ, Madsbad S, Bojsen-Møller KN. Wewer Albrechtsen NJ, et al. Among authors: rashu eb. Diabetes Obes Metab. 2022 Oct;24(10):2017-2026. doi: 10.1111/dom.14789. Epub 2022 Jul 21. Diabetes Obes Metab. 2022. PMID: 35676803 Free PMC article. Clinical Trial.
12 results